|
Tolerance induction with vitamin d3-treated myelin-loaded dendritic cells in patients with multiple sclerosis.
|
PI16/01797
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
55.055,00€
|
ERDF funds
|
|
Study of the interaction of adipokines and myokines in the development of obesity and associated comorbidities.
|
PI16/00221
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
92.565,00€
|
ERDF funds
|
|
Changes in adipose tissue plasticity after bariatric surgery and its role in the improvement of associated comorbidities.
|
PI16/01217
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
260.452,50€
|
ERDF funds
|
|
Reduction of the radiation dose received by the patient in the PET/CT programs of study .
|
PI16/00270
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
50.215,00€
|
ERDF funds
|
|
Both phenotypic and genotypic characterization of histaminergic angioedema.
|
PI16/01304
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
90.750,00€
|
ERDF funds
|
|
Study of the antifibrogenic action of omega-3 fatty acids : Therapeutic applications.
|
PI16/02081
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
139.755,00€
|
ERDF funds
|
|
TMPRSS4: a novel biomarker and therapeutic target in poor prognosis squamous cell lung carcinoma
|
PI16/01352
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
development based on the identification, analysis and inhibition of non-coding genes involved in the progression of hepatocellular carcinoma.
progression of hepatocarcinoma.
|
PI16/01845
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
163.652,50€
|
ERDF funds
|
|
Dissection of the mechanisms of post-resection and post-brachytherapy local recurrences.
|
Pi16/01847
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
80.465,00€
|
ERDF funds
|
|
Effect of weight loss with hypocaloric Mediterranean per diem expenses and promotion of physical activity on primary caridovascular prevention: The predimed-plus study.
|
Pi16/01522
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
118.882,50€
|
ERDF funds
|
|
integrated cytometry and next-generation ultrasequencing model to unveil the pathogenesis of acute myeloblastic leukemia and define new response criteria
and define new response criteria for acute myeloblastic leukemia
|
PI16/01661
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
236.857,50€
|
ERDF funds
|
|
EPICA: Dual epigenetic targeting and immunotherapy to fight against cancer.
|
AC16/00041
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
144.159,40€
|
ERDF funds
|
|
HEPAMUT: Mutated neo-antigens in hepatocellular carcinoma.
|
AC16/00065
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
87.216,80€
|
ERDF funds
|
|
LYMIT-DIS: Targeted lymphatic and microvessel treatment in metabolic-disease HFpEF
|
AC16/00020
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
ERA-CVD
|
30-11-2016
|
99.825,00€
|
ERDF funds
|
|
LIPCAR-HF: Lipcar, a prognostic marker of heart failure with reduced ejection fraction.
|
AC16/00016
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
ERA-CVD
|
30-11-2016
|
99.746,35€
|
ERDF funds
|
|
Role of the NKX2-3 homeobox protein in the biology and therapy of marginal zone B lymphomas.
|
PI16/00581
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
236.252,50€
|
ERDF funds
|
|
Detection and functional validation of plasma cell-specific long non-coding RNAs in Multiple Myeloma.
|
PI16/02024
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
Potential of in vivo gene editing using CRISPR/Cas for the treatment and modeling of primary hyperoxaluria.
|
PI16/00150
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
80.465,00€
|
ERDF funds
|
|
New experimental approaches to the diagnosis and treatment of cholangiocarcinoma.
|
PI16/01126
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
96.195,00€
|
ERDF funds
|
|
Molecular analysis of non-small cell lung carcinoma using state-of-the-art platforms for the development of prognostic profiles and new therapeutic tools.
|
PI16/01821
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
128.865,00€
|
ERDF funds
|
|
|
|
|
|
|
|
|
